Search Within

Natalia Polidorio Machado

Formats
  1. Meeting Abstract (6)
  2. Journal Article (4)
  3. Miscellaneous (2)
Groups
  1. Surgery (10)
  2. Epidemiology and Biostatistics (9)
  3. Principal Biostatisticians (8)
  4. Graduate Medical Education (6)
  5. GME, Surgery (4)
  6. Survivorship Research (2)

More Groups

People
  1. Monica Morrow (8)
  2. Srinivasa Sevilimedu Veeravalli (8)
  3. Stephanie Downs-Canner (6)
  4. Giacomo Montagna (5)
  5. Nour Abuhadra (5)
  6. George Plitas (4)

More People

Years
  1. 2025 (4)
  2. 2024 (7)
  3. 2023 (1)
Publications
  1. Annals of Surgical Oncology (7)
  2. Journal of Clinical Oncology (2)
  3. European Journal of Cancer (1)
  4. JNCI: Journal of the National Cancer Institute (1)
  5. Laboratory Investigation (1)
Publishers
  1. Springer (7)
  2. American Society of Clinical Oncology (2)
  3. Elsevier Inc. (1)
  4. Nature Publishing Group (1)
  5. Oxford University Press (1)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Timing of neoadjuvant pembrolizumab infusion and pathologic complete response among patients with triple-negative breast cancer receiving the KEYNOTE-522 regimen
    Meeting Abstract

    Shen, S.; Myers, S.; Polidorio, N.; Bromberg, M.; Chen, Y.; Tan, R.; Mai, N.; Abuhadra, N.; Traina, T. A.; Downs-Canner, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Predictors of pathologic complete response with neoadjuvant chemo-immunotherapy in early-stage triple-negative breast cancer
    Journal Article

    Perry, L. M.; Sevilimedu, V.; Polidorio, N.; Abuhadra, N.; Morrow, M.; Plitas, G.; Downs-Canner, S.
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Predictors of pathologic complete response with neoadjuvant chemo-immunotherapy in early-stage triple-negative breast cancer
    Miscellaneous

    Perry, L. M.; Sevilimedu, V.; Polidorio, N.; Abuhadra, N.; Morrow, M.; Plitas, G.; Downs-Canner, S.
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Clinicopathologic features, genomic profiles and neoadjuvant chemotherapy response in triple negative breast cancer according to androgen receptor expression
    Meeting Abstract

    Vougiouklakis, T.; Polidorio, N.; Downs-Canner, S.; Schwartz, C.; Brogi, E.; Montagna, G.; Wen, H.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome
    Journal Article

    Bottosso, M.; Sandoval, R. L.; Verret, B.; Polidorio, N.; Caron, O.; Gennari, A.; Bychkovsky, B. L.; Cahill, S. H.; Achatz, M. I.; Guarneri, V.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • TP53-associated early breast cancer: New observations from a large cohort
    Journal Article

    Sandoval, R. L.; Bottosso, M.; Li, T. Y.; Polidorio, N.; Bychkovsky, B. L.; Verret, B.; Gennari, A.; Cahill, S.; Achatz, M. I.; Caron, O.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Predictors of pathologic complete response with neoadjuvant chemo-immunotherapy in early-stage triple-negative breast cancer
    Meeting Abstract

    Perry, L. M.; Sevilimedu, V.; Polidorio, N.; Abuhadra, N.; Morrow, M.; Plitas, G.; Downs-Canner, S.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Impact of race and ethnicity on recurrence risk in patients with ductal carcinoma in situ treated with breast-conserving surgery
    Meeting Abstract

    Polidorio, N.; Jones, V. M.; Sevilimedu, V.; Morrow, M.; Van Zee, K. J.; Barrio, A. V.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Impact of race on pathologic complete response with neoadjuvant chemo-immunotherapy and chemotherapy alone for early-stage triple-negative breast cancer
    Meeting Abstract

    Polidorio, N.; Perry, L. M.; Sevilimedu, V.; Montagna, G.; Abuhadra, N.; Morrow, M.; Downs-Canner, S.; Plitas, G.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Do HER2-low tumors have a distinct clinicopathologic phenotype?
    Journal Article

    Polidorio, N.; Montagna, G.; Sevilimedu, V.; Le, T.; Morrow, M.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save